These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 23466342

  • 1. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
    Tran TP, Kim HG, Choi JH, Na MK, Jeong HG.
    Phytomedicine; 2013 May 15; 20(7):622-31. PubMed ID: 23466342
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
    Hien TT, Kim HG, Han EH, Kang KW, Jeong HG.
    Mol Nutr Food Res; 2010 Jul 15; 54(7):918-28. PubMed ID: 20077420
    [Abstract] [Full Text] [Related]

  • 3. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.
    Toxicol In Vitro; 2010 Sep 15; 24(6):1474-81. PubMed ID: 20656007
    [Abstract] [Full Text] [Related]

  • 4. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul 15; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 5. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.
    Kim HG, Hien TT, Han EH, Hwang YP, Choi JH, Kang KW, Kwon KI, Kim BH, Kim SK, Song GY, Jeong TC, Jeong HG.
    Br J Pharmacol; 2011 Mar 15; 162(5):1096-108. PubMed ID: 21054339
    [Abstract] [Full Text] [Related]

  • 6. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line.
    Lin X, Zhang X, Wang Q, Li J, Zhang P, Zhao M, Li X.
    Neoplasma; 2012 Mar 15; 59(3):248-56. PubMed ID: 22329846
    [Abstract] [Full Text] [Related]

  • 7. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
    Zhang J, Lu M, Zhou F, Sun H, Hao G, Wu X, Wang G.
    Drug Metab Dispos; 2012 Oct 15; 40(10):1900-8. PubMed ID: 22745335
    [Abstract] [Full Text] [Related]

  • 8. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F, Fan J, Wu Z, Liu RY, Guo L, Dong Z, Wang Z.
    Pharm Biol; 2013 Sep 15; 51(9):1196-203. PubMed ID: 23777360
    [Abstract] [Full Text] [Related]

  • 9. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.
    Choi BH, Kim CG, Lim Y, Shin SY, Lee YH.
    Cancer Lett; 2008 Jan 18; 259(1):111-8. PubMed ID: 18006147
    [Abstract] [Full Text] [Related]

  • 10. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 18; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 11. Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.
    Gao A, Liang H, Wang X, Zhang X, Jing M, Zhang J, Yan Y, Xiang W.
    Eur J Pharmacol; 2011 Jun 01; 659(2-3):108-13. PubMed ID: 21458446
    [Abstract] [Full Text] [Related]

  • 12. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A, Wang X, Xiang W, Liang H, Gao J, Yan Y.
    J Pharm Pharmacol; 2010 Mar 01; 62(3):393-9. PubMed ID: 20487225
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.
    J Cell Biochem; 2013 Aug 01; 114(8):1890-900. PubMed ID: 23494858
    [Abstract] [Full Text] [Related]

  • 14. Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity.
    Wang Z, Zhang L, Ni Z, Sun J, Gao H, Cheng Z, Xu J, Yin P.
    Tumour Biol; 2015 Dec 01; 36(12):9499-510. PubMed ID: 26124005
    [Abstract] [Full Text] [Related]

  • 15. A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells.
    Xue P, Yang X, Liu Y, Xiong C, Ruan J.
    Biomed Pharmacother; 2014 Oct 01; 68(8):1049-56. PubMed ID: 25455158
    [Abstract] [Full Text] [Related]

  • 16. Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells.
    Do MT, Hwang YP, Kim HG, Na M, Jeong HG.
    J Cell Physiol; 2013 May 01; 228(5):1087-97. PubMed ID: 23065756
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
    Yamagishi N, Nakao R, Kondo R, Nishitsuji M, Saito Y, Kuga T, Hatayama T, Nakayama Y.
    Biochem Biophys Res Commun; 2014 Jun 13; 448(4):430-6. PubMed ID: 24796664
    [Abstract] [Full Text] [Related]

  • 18. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 13; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 19. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
    Jiang J, Wang X, Cheng K, Zhao W, Hua Y, Xu C, Yang Z.
    Mol Med Rep; 2016 Jun 13; 13(6):4745-50. PubMed ID: 27082231
    [Abstract] [Full Text] [Related]

  • 20. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.
    Ma B, Chai S, Li N, To KK, Kan WL, Yang D, Lin G.
    Int J Pharm; 2012 Mar 15; 424(1-2):33-9. PubMed ID: 22226881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.